Optimal heart rate control for patients with chronic atrial fibrillation: Are pharmacologic choices truly changing?
Open Access
- 31 May 1992
- journal article
- editorial
- Published by Elsevier in American Heart Journal
- Vol. 123 (5), 1401-1403
- https://doi.org/10.1016/0002-8703(92)91058-9
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Stroke Prevention in Atrial Fibrillation Study. Final results.Circulation, 1991
- Digoxin for Atrial Fibrillation: A Drug Whose Time Has Gone?Annals of Internal Medicine, 1991
- Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials.Circulation, 1990
- Different cardiodepressant potency of various calcium antagonists in human myocardiumThe American Journal of Cardiology, 1990
- Efficacy and safety of intravenous diltiazem for treatment of atrial fibrillation and atrial flutterThe American Journal of Cardiology, 1989
- Efficacy and safety of medium- and high-dose diltiazem alone and in combination with digoxin for control of heart rate at rest and during exercise in patients with chronic atrial fibrillation.Circulation, 1986
- Exercise heart rates at different serum digoxin concentrations in patients with atrial fibrillation.BMJ, 1985
- Superiority of Oral Verapamil Therapy to Digoxin in Treatment of Chronic Atrial FibrillationChest, 1983
- Epidemiologic Features of Chronic Atrial FibrillationNew England Journal of Medicine, 1982
- Inefficacy of digitalis in the control of heart rate in patients with chronic atrial fibrillation: Beneficial effect of an added beta adrenergic blocking agentThe American Journal of Cardiology, 1979